Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

6 June 2013

Pronota Is To Receive Patent On Biomarker For Diagnosing Renal Failure In The US Despite Prometheus.More

5 November 2012

International Consortium Awarded 6 Million Euro To Validate Pre-Eclampsia Early Detection Tests.More

2 November 2012

Genkyotex's NOX Inhibitor GKT137831 Phase I Data Presented at Kidney Week 2012.More

25 October 2012

Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury.More

17 October 2012

Covagen enters into a strategic research collaboration and
license agreement with Mitsubishi Tanabe for the development of
bispecific FynomAbs.More

 

 

Featured Portfolio